Donglu Wu

623 total citations
18 papers, 474 citations indexed

About

Donglu Wu is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Donglu Wu has authored 18 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Cancer Research. Recurrent topics in Donglu Wu's work include Ginseng Biological Effects and Applications (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Epigenetics and DNA Methylation (4 papers). Donglu Wu is often cited by papers focused on Ginseng Biological Effects and Applications (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Epigenetics and DNA Methylation (4 papers). Donglu Wu collaborates with scholars based in China, United States and Saint Kitts and Nevis. Donglu Wu's co-authors include Da Liu, Jingji Jin, Haoming Luo, Yong Cai, Zhidong Qiu, Xue Meng, Zhidong Qiu, Ye Qiu, Rui Zhang and Jian Ding and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Donglu Wu

16 papers receiving 470 citations

Peers

Donglu Wu

PHARM

ONCOL

IMMUN

Robert Kleszcz Poland

Jessica Roos Germany

Seema Noor Germany

Xianjun Yu China

Xiaonan Xi China

Norberto A. Gandini Argentina

Chiara De Ciucis Italy

Wanzhou Zhao China

Sofia E. Gomes Portugal

Jose Thaiparambil United States

Robert Kleszcz Poland

Donglu Wu

356 ×1.0

67 ×0.9

PHARM

119 ×1.5

94 ×1.7

ONCOL

33 ×0.7

IMMUN

Citations per year, relative to Donglu Wu Donglu Wu (= 1×) peers Robert Kleszcz

Countries citing papers authored by Donglu Wu

Since Specialization

Citations

This map shows the geographic impact of Donglu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donglu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donglu Wu more than expected).

Fields of papers citing papers by Donglu Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donglu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donglu Wu. The network helps show where Donglu Wu may publish in the future.

Co-authorship network of co-authors of Donglu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Donglu Wu. A scholar is included among the top collaborators of Donglu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donglu Wu. Donglu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wang, Lei, Liting Zhao, Ming Zhu, et al.. (2025). Lysine Acetyltransferase 8: A Target for Natural Compounds in Cancer Therapy. International Journal of Molecular Sciences. 26(11). 5257–5257.

Liu, Zhimei, et al.. (2024). Can O-GIcNAc Transferase (OGT) Complex Be Used as a Target for the Treatment of Hematological Malignancies?. Pharmaceuticals. 17(6). 664–664. 2 indexed citations

Fan, Meiling, et al.. (2023). Renal function protection and the mechanism of ginsenosides: Current progress and future perspectives. Frontiers in Pharmacology. 14. 1070738–1070738. 18 indexed citations

Fang, Xiaoxue, Zhidong Qiu, Da Liu, et al.. (2023). Cryptotanshinone, a Potential SIRT3 Inhibitor, Suppresses Colorectal Cancer Proliferation in vitro and in vivo. Natural Product Communications. 18(8). 1 indexed citations

Fan, Meiling, et al.. (2022). Anti-cancer effect and potential microRNAs targets of ginsenosides against breast cancer. Frontiers in Pharmacology. 13. 1033017–1033017. 12 indexed citations

Fan, Meiling, Tianjia Liu, Donglu Wu, et al.. (2022). Ginsenoside Rd protects transgenic Caenorhabditis elegans from β-amyloid toxicity by activating oxidative resistant. Frontiers in Pharmacology. 13. 1074397–1074397. 12 indexed citations

Meng, Lu, et al.. (2022). Salvia miltiorrhiza in cancer: Potential role in regulating MicroRNAs and epigenetic enzymes. Frontiers in Pharmacology. 13. 1008222–1008222. 7 indexed citations

Zheng, Qi‐Yu, Zhidong Qiu, Lingling Cao, et al.. (2021). In Vitro Validation of Network Pharmacology Predictions: Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Cell Proliferation via SIRT2. Natural Product Communications. 16(4). 2 indexed citations

Dong, Jinxiang, Lijie Song, Fuqiang Li, et al.. (2021). Network Pharmacology Validation of Therapeutic Mechanisms of Tanshinone IIA in Colorectal Cancer. Natural Product Communications. 16(3).

10.

Wu, Donglu, et al.. (2020). Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy. Frontiers in Oncology. 10. 560487–560487. 54 indexed citations

11.

Wu, Donglu, Jingji Jin, Zhidong Qiu, Da Liu, & Haoming Luo. (2020). Functional Analysis of O-GlcNAcylation in Cancer Metastasis. Frontiers in Oncology. 10. 585288–585288. 30 indexed citations

12.

Liu, Da, Xue Meng, Donglu Wu, Zhidong Qiu, & Haoming Luo. (2019). A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine. Frontiers in Pharmacology. 10. 9–9. 125 indexed citations

13.

Wu, Donglu, Yong Cai, & Jingji Jin. (2017). Potential coordination role between O-GlcNAcylation and epigenetics. Protein & Cell. 8(10). 713–723. 42 indexed citations

14.

Wu, Donglu, Linhong Zhao, Chao Yu, et al.. (2017). O-Linked N-acetylglucosamine transferase 1 regulates global histone H4 acetylation via stabilization of the nonspecific lethal protein NSL3. Journal of Biological Chemistry. 292(24). 10014–10025. 16 indexed citations

15.

Liu, Da, Donglu Wu, Linhong Zhao, et al.. (2015). Arsenic Trioxide Reduces Global Histone H4 Acetylation at Lysine 16 through Direct Binding to Histone Acetyltransferase hMOF in Human Cells. PLoS ONE. 10(10). e0141014–e0141014. 40 indexed citations

16.

Zhao, Xiaoming, Jiaming Su, Fei Wang, et al.. (2013). Crosstalk between NSL Histone Acetyltransferase and MLL/SET Complexes: NSL Complex Functions in Promoting Histone H3K4 Di-Methylation Activity by MLL/SET Complexes. PLoS Genetics. 9(11). e1003940–e1003940. 43 indexed citations

17.

Wang, Yong, Rui Zhang, Donglu Wu, et al.. (2013). Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma. Journal of Experimental & Clinical Cancer Research. 32(1). 8–8. 45 indexed citations

18.

Wu, Donglu, Rui Zhang, Rui Zhao, et al.. (2013). A Novel Function of Novobiocin: Disrupting the Interaction of HIF 1α and p300/CBP through Direct Binding to the HIF1α C-Terminal Activation Domain. PLoS ONE. 8(5). e62014–e62014. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact